3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
51
Urinary Bladder Neoplasms
15
Breast Neoplasms
10
Carcinoma, Renal Cell
8
Colorectal Neoplasms
7
Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Carcinoma, Transitional Cell
5
Carcinoma, Non-Small-Cell Lung
4
Motor Activity
3
Colonic Neoplasms
3
Urologic Neoplasms
2
Urologic Diseases
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Recurrence
2
Rectal Neoplasms
2
Prostate Cancer Metastatic
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Melanoma
2
Kidney Neoplasms
2
Kidney Failure, Chronic
2
Esophageal Neoplasms
2
COVID-19
2
Breast Neoplasms, Male
2
Interventions
trametinib
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Progressive Metastatic Castrate Resistant Prostate Cancer
×
Standard of Care
×
Genitourinary
×
Clear all
NCT07206056
2026-06-03
TulmiSTAR-01
Novartis
Phase 1/2
Recruiting
188 enrolled